PET MRI in Coronary Artery Disease

NCT03451448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-05-21

No results posted yet for this study

Summary

This study will assess the use of position emission tomography/magnetic resonance imaging (PET/MRI) using ultra-small-superparamagnetic particles of iron oxide (USPIO) as a contrast agent in patients with coronary artery disease.

Conditions

Interventions

DIAGNOSTIC_TEST

PET/MRI

PET/MRI with USPIO contrast

DIAGNOSTIC_TEST

MRI

MRI with USPIO contrast

Sponsors & Collaborators

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Michelle Williams · University of Edinburgh

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2023-05-01
Completion
2024-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451448 on ClinicalTrials.gov